Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 31:12:31-40.
doi: 10.2174/1874205X01812010031. eCollection 2018.

The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians

Affiliations
Review

The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians

Christos Bakirtzis et al. Open Neurol J. .

Abstract

About half of patients with multiple sclerosis exhibit cognitive impairment which negatively affects their quality of life. The assessment of cognitive function in routine clinical practice is still undervalued, although various tools have been proposed for this reason. In this article, we describe the potential benefits of implementing cognitive assessment tools in routine follow -ups of MS patients. Early detection of changes in cognitive performance may provide evidence of disease activity, could unmask depression or medication side-effects and provide suitable candidates for cognitive rehabilitation. Since apathy and cognitive deficiencies are common presenting symptoms in Progressive Multifocal Leukoencephalopathy, we discuss the utility of frequent monitoring of mental status in multiple sclerosis patients at increased risk. In addition, we propose a relevant algorithm aiming to incorporate a systematic evaluation of cognitive function in every day clinical practice in multiple sclerosis.

Keywords: Clinical practice; Cognition; Depression; Fatigue; Monitoring; Multiple sclerosis.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)

References

    1. Lublin F, Reingold S, Cohen J, et al. Defining the clinical course of multiple sclerosis. Neurology 2014; 15; 83(3): 278–286. - PMC - PubMed
    1. Dutta R., Trapp B.D. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 2011;93(1):1–12. doi: 10.1016/j.pneurobio.2010.09.005. - DOI - PMC - PubMed
    1. Jongen P.J., Ter Horst A.T., Brands A.M. Cognitive impairment in multiple sclerosis. Minerva Med. 2012;103(2):73–96. - PubMed
    1. Rae-Grant A., Bennett A., Sanders A.E., Phipps M., Cheng E., Bever C. Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary. Neurology. 2015;85(21):1904–1908. doi: 10.1212/WNL.0000000000001965. - DOI - PMC - PubMed
    1. Saccà F., Costabile T., Carotenuto A., Lanzillo R., Moccia M., Pane C., Russo C.V., Barbarulo A.M., Casertano S., Rossi F., Signoriello E., Lus G., Brescia Morra V. The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests. Mult. Scler. 2017;23(9):1289–1296. doi: 10.1177/1352458516677592. - DOI - PubMed

LinkOut - more resources